The Food and Drug Administration is not willing to expand the approval of an existing drug for enlarged prostates as a means to reduce the risk of prostate cancer. A panel of expert previously recommended against the expansion.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/01/27/133271291/avodart-gets-rejected-by-fda-for-reducing-prostate-cancer-risk?ft=1&f=103537970
Posted
Jan 27 2011, 11:27 AM
by
NPR Blogs: Shots - Health News Blog